JPH0920791A - Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production - Google Patents

Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production

Info

Publication number
JPH0920791A
JPH0920791A JP7168616A JP16861695A JPH0920791A JP H0920791 A JPH0920791 A JP H0920791A JP 7168616 A JP7168616 A JP 7168616A JP 16861695 A JP16861695 A JP 16861695A JP H0920791 A JPH0920791 A JP H0920791A
Authority
JP
Japan
Prior art keywords
substance
methanol
chitin
culture
chloroform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7168616A
Other languages
Japanese (ja)
Inventor
Fusao Tomita
房男 冨田
Mina Kanda
三奈 神田
Noriko Chiba
紀子 千葉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Priority to JP7168616A priority Critical patent/JPH0920791A/en
Publication of JPH0920791A publication Critical patent/JPH0920791A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the new subject substance exhibiting an antifungous action against fungous variants defected in chitin-synthesizing enzyme I which is a cellular wall-synthesizing enzyme, and useful for agriculture etc., by culturing a microorganism belonging to the genus Leptosphaeria sp. and having an ability for producing the AM-1 substance. SOLUTION: A new AM-1 substance having following characteristics. The mol. wt. (m/z): 337 (FAB-MS); molecular formula: C22 H43 ON; UV absorption spectrum has maximum absorption peaks at 248nm and 286(sh)nm; Rf value is 0.05 in a development solvent of benzene:acetone (7:3), 0.25 in chloroform- methanol (7:3), 0.28 in benzene:chloroform:ethyl ether (8:2:1:1) in a thin layer chromatography, and positive for an iodine reaction. The compound is obtained by culturing a microorganism belonging to the genus Leptosphaeria sp. and having an ability for producing the AM-1 substance and subsequently collecting the substance from the culture product.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、真菌の細胞壁合成酵素
であるキチン合成酵素1を欠損する変異株に対して抗真
菌活性を示し、野生株には抗真菌活性を示さない新しい
タイプの抗真菌剤となりうるAM−1物質及びその製造
法に関するものである。
The present invention relates to a novel type of antifungal which exhibits antifungal activity against a mutant strain deficient in chitin synthase 1 which is a fungal cell wall synthase, and which does not exhibit antifungal activity in a wild strain. The present invention relates to an AM-1 substance that can be a fungal agent and a method for producing the same.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】近年、
真菌類にのみ作用するという選択毒性を有する新しい真
菌剤の必要性が高まっている。選択毒性を生む機構には
細胞の種類による薬剤の活性化および不活性化、細胞膜
の透過性など様々なものがあるが、なかでも動物細胞に
は存在しない微生物の細胞壁の構成成分の生合成を阻害
することでより高い選択毒性が期待されることが知られ
ている。真菌類の細胞壁の構造は細菌の場合とは大きく
異なり、蛋白質、脂質、多糖類、無機塩類などから成る
が、中でもN−アセチルグルコサミンのβ(1→4)結
合産物であるキチンと、グルコースのβ(1→3)結合
産物であるβ−1,3グルカンは、多くの真菌類で細胞
壁の主要構成成分となっている。
2. Description of the Related Art In recent years,
There is a growing need for new fungal agents with selective toxicity that act only on fungi. There are various mechanisms that produce selective toxicity, such as activation and inactivation of drugs depending on cell type, permeability of cell membranes, etc. Among them, biosynthesis of cell wall constituents of microorganisms that do not exist in animal cells is involved. It is known that higher selective toxicity is expected by inhibiting. The structure of the cell wall of fungi differs greatly from that of bacteria, and consists of proteins, lipids, polysaccharides, inorganic salts, etc. Among them, β- (1 → 4) -binding product of N-acetylglucosamine, chitin, and glucose β-1,3 glucan, which is a β (1 → 3) binding product, is a major constituent of the cell wall in many fungi.

【0003】ところで、真菌類のキチン合成酵素はその
予想されるアミノ酸配列をもとに生物種を越えて4つに
分類されており、細胞壁形成に対し複雑に役割分担をし
ていることが知られている。Cabibは酵母の3つの
キチン合成酵素(CHS1,CHS2,CHS3)につ
いてCHS1は酵母の隔壁形成に必須ではないもののキ
チン合成に関与していること、CHS2は隔壁形成を行
いもともと薬剤に阻害されにくいということ、CHS3
は細胞壁のほとんどのキチンを合成しCHS2とCHS
3の二重の欠損によって致死にいたる、と報告している
[Proc.Natl.Acad.Sci.USA,
,4735−4739(1988)およびProc.
Natl.Acad.Sci.USA,91,4727
−4730(1990)]。
By the way, it is known that fungal chitin synthases are classified into four groups based on their predicted amino acid sequences, regardless of the species of organisms, and play a complex role in cell wall formation. Has been. Cabib is related to three yeast chitin synthases (CHS1, CHS2, CHS3). CHS1 is involved in chitin synthesis although it is not essential for yeast septum formation, and CHS2 is difficult to be originally inhibited by drugs. That, CHS3
Synthesizes most of the chitin in the cell wall, CHS2 and CHS
It has been reported to be fatal due to the double deletion of 3 [Proc. Natl. Acad. Sci. USA, 8
5 , 4735-4739 (1988) and Proc.
Natl. Acad. Sci. USA, 91 , 4727
-4730 (1990)].

【0004】現在、真菌類のキチン合成酵素を欠損する
変異株に対する抗菌活性に注目した農業用抗生物質とし
ては、ポリオキシンが知られているが、上記のようにそ
の他の新しいタイプの真菌剤が求められているのが現状
である。
At present, polyoxine is known as an agricultural antibiotic with a focus on the antibacterial activity against fungal chitin synthase-deficient mutants, but as described above, other new types of fungal agents are required. This is the current situation.

【0005】[0005]

【発明を解決するための手段】本発明者らは、キチン合
成酵素1欠損株と野生株とを使ったペーパーディスク法
を用いて微生物培養液からのキチン合成酵素阻害剤の探
索を試みた。その結果、レプトスフェリア属に属する菌
株の培養物中にキチン合成酵素1を欠損する変異株に対
して抗真菌活性を示し、野生株には抗真菌活性を示さな
い新しいタイプの抗真菌剤となりうる新規物質が生産さ
れていることを見出し、本発明を完成するに至った。
The present inventors have tried to search for a chitin synthase inhibitor from a microbial culture by using the paper disk method using a chitin synthase 1 deficient strain and a wild strain. As a result, it can be a new type of antifungal agent that exhibits antifungal activity against a mutant strain lacking chitin synthase 1 in the culture of a strain belonging to the genus Leptosperia and does not exhibit antifungal activity in a wild strain. It was found that a new substance was produced, and the present invention was completed.

【0006】すなわち、本発明の要旨は下記の理化学的
性質を有するAM−1物質及びその製造法に存する。 (1)分子量:m/z=337(FAB−MS) (2)分子式:C2243ON (3)紫外部吸収スペクトル:メタノール中、248n
mおよび286(sh)nmに吸収極大を有する (4)薄層クロマトグラフィー:以下の展開溶媒条件で
以下のRf値を示す
That is, the gist of the present invention resides in an AM-1 substance having the following physicochemical properties and a method for producing the same. (1) Molecular weight: m / z = 337 (FAB-MS) (2) Molecular formula: C 22 H 43 ON (3) Ultraviolet absorption spectrum: in methanol, 248 n
Absorption maxima at m and 286 (sh) nm (4) Thin layer chromatography: The following Rf values are shown under the following developing solvent conditions.

【0007】[0007]

【表2】 [Table 2]

【0008】(5)呈色反応:ヨウ素反応に陽性 以下本発明につき詳細に説明する。本発明のAM−1物
質(以下「本発明化合物」と略記することもある)は、
たとえば本発明化合物を生産する能力を有するレプトス
フェリア(Leptosphaeria)属に属する微
生物を培養し、その培養液から採取することができる。
かかる微生物としてはレプトフェリア属に属し、本発明
化合物を生産する能力を有するものであれば特に制限は
されない。具体的には本発明者らにより、沖縄県、慶佐
次川村で採取した双子葉植物体上より、新たに分離した
小房子嚢菌網に属するレプトスフェリア・エスピー(L
eptosphaeria sp.)MCI2799
(以下「本菌株」、「MCI2799」または「MCI
2799株」と略記することもある)がより好ましい菌
として挙げられる。なお、本菌株は工業技術院生命工学
工業技術研究所に生工研菌寄第15016号(FERM
P−15016)として寄託されている。MCI279
9株の菌学的性状は下記の通りである。
(5) Color reaction: positive for iodine reaction The present invention will be described in detail below. The AM-1 substance of the present invention (hereinafter sometimes abbreviated as “the compound of the present invention”) is
For example, a microorganism belonging to the genus Leptosphaeria capable of producing the compound of the present invention can be cultured and collected from the culture solution.
The microorganism is not particularly limited as long as it belongs to the genus Leptopheria and has the ability to produce the compound of the present invention. Specifically, by the present inventors, from the dicotyledonous plant collected in Keisatsugawa-mura, Okinawa Prefecture, Leptosperia sp.
eptosphereia sp. ) MCI2799
(Hereinafter "this strain", "MCI2799" or "MCI
It may be abbreviated as "2799 strain"). In addition, this strain was produced by the Institute of Biotechnology, National Institute of Industrial Science and Technology, Biotechnology Research Institute, No. 15016 (FERM
It has been deposited as P-15016). MCI279
The bacteriological properties of the 9 strains are as follows.

【0009】1)形態学的特徴 偽嚢殻は宿主植物上に散在して生じる、植物組織内に埋
没して生じ、のちに頚部を表皮上に突出させる、亜球形
〜やや扁平、直径230〜380μm。頚部は著しく発
達し乳頭形。偽嚢殻の殻壁は比較的薄く、偽柔組織状、
厚さは8〜11μm。子嚢は多数生じる、こん棍形で長
い柄(pedicel)を有す、120〜132μm×
20.0〜24.5μm、明瞭な二重壁構造、8胞子
性。偽側糸は豊富に生じ、糸状、隔壁を有する。子嚢胞
子は子嚢中に2〜1列に配列する(子嚢上方部は2列、
下部で1列)、25.9〜34.1μm×8.4×10
μm、だ円形〜スリッパ状。濃い暗褐色、通常3−隔
壁、稀に4−隔壁を有する、第2細胞やや膨大する、隔
壁部でやや狭窄する。付属体を欠く。
1) Morphological characteristics Pseudocysts are scattered on the host plant, are embedded in plant tissue, and then cause the neck to protrude onto the epidermis. Subglobular to slightly flattened, diameter 230 to 380 μm. The neck is markedly developed and papillary. Pseudocysts have a relatively thin shell wall, pseudosoft tissue,
The thickness is 8 to 11 μm. 120-132 μm with a long, stalk-shaped pedicle as a result
20.0-24.5 μm, clear double-walled structure, 8-sporic. False side yarns occur abundantly and have filaments and septa. Ascospores are arranged in 2 to 1 rows in the asci (two rows in the upper part of the ascos),
1 row at the bottom), 25.9-34.1 μm × 8.4 × 10
μm, oval to slipper shape. Dark dark brown, usually 3 septa, rarely 4 septa, slightly enlarged second cells, slightly constricted at septum. It lacks an appendage.

【0010】2)各種培地上における特徴 ジャガイモ・ブドウ糖寒天培地(PDA)上、24
℃、2週間培養 コロニーは2週間で、直径4.5cmに拡がる、コロニ
ー色調は、はじめ白色、のちに暗い灰色を呈する、基底
菌糸は放射状に伸び、分枝する、巾3.0〜5.6μ
m、隔壁を有する。気生菌糸は豊富に形成される。本培
地上ではアナモルフ及びテレオモルフの形成は観察され
なかった。 麦芽寒天培地(MA)上、24℃、2週間培養 コロニーは2週間で、直径3〜4cmに拡がる、色調
は、はじめ白色、のちに灰色がかった褐色を呈する、基
底菌糸は放射状に伸び、分枝する、巾4.0〜6.8μ
m、隔壁を有する。気生菌糸の発達は中程度。本培地上
ではアナモルフ及びテレオモルフの形成は観察されなか
った。
2) Characteristics on various media 24 on potato-glucose agar medium (PDA)
C., 2 weeks culture Colonies spread to 4.5 cm in diameter for 2 weeks. The color tone of the colony is initially white, then dark gray. Basal hyphae radially extend and branch, width 3.0-5. 6μ
m, having a partition wall. Aerial hyphae are abundantly formed. No formation of anamorph and teleomorph was observed on this medium. Cultivated on malt agar medium (MA) at 24 ° C. for 2 weeks. The colony spreads to a diameter of 3 to 4 cm in 2 weeks. The color tone is initially white, then grayish brown, and the basal hyphae extend radially and Branching, width 4.0-6.8μ
m, having a partition wall. Development of aerial hyphae is moderate. No formation of anamorph and teleomorph was observed on this medium.

【0011】3)生理的性質 最適生育条件 最適pH:4〜6 (三浦培地(LCA)液体培地中、2
週間培養) 最適温度:20〜27℃(PDA培地上、2週間培養) 生育の範囲 pH範囲:pH3〜8(LCA液体培地中、2週間培
養) 温度範囲:15〜30℃で生育、37℃では生育せず
(PDA培地上、2週間培養)
3) Physiological properties Optimal growth conditions Optimum pH: 4 to 6 (in Miura medium (LCA) liquid medium, 2
Weekly culture) Optimum temperature: 20-27 ° C (on PDA medium for 2 weeks) Growth range pH range: pH 3-8 (in LCA liquid medium for 2 weeks) Temperature range: 15-30 ° C, 37 ° C Does not grow (cultivated on PDA medium for 2 weeks)

【0012】4)分類学的考察 高次の分類学上の位置 本菌株(MCI2799)は1)双子葉植物体上に生
じ、2)亜球形〜偏平状の偽嚢殻を形成する、3)子嚢
は明瞭な二重壁構造を持つ、4)永続性の偽側糸(ps
eudoparaphysis)が存在する、5)子嚢
胞子は多細胞であることから、L.Holm,Sym
b.Botan.Upsal.,14(3):1〜18
8(1957),E.S.Luttrell,Locu
loascomycetes,The Fungi,v
ol.4A(ed.G.C.Ainsworth et
al.):135〜219(1973),J.A.v
onArx&E.Muller,Stud.Myco
l.,:1〜159(1975),及びA.Siva
nesan,The Bitunicate Asco
mycetes,339〜358(1984),J.C
ramerの分類表にある小房子嚢菌網(Loculo
ascomycetes)ープレオスポラ目(Pleo
sporales)ープレオスポラ科(Pleospo
raceae)に位置することが判明した。
4) Taxonomic Consideration Higher taxonomic position This strain (MCI2799) 1) occurs on dicotyledonous plants, 2) forms a pseudospherical shell of subglobular to flat shape, 3) Ascos have clear double-walled structure, 4) Persistent pseudolateral yarn (ps)
euphoraphysis), and 5) ascospores are multicellular, L. Holm, Sym
b. Botan. Upsal. , 14 (3): 1-18
8 (1957), E.I. S. Lutrell, Locu
loacomycetes, The Fungi, v
ol. 4A (ed.GC Ainsworth et
al. ): 135-219 (1973), J. A. v
onArx & E. Muller, Stud. Myco
l. , 9 : 1-159 (1975), and A. Siva
nesan, The Bitunicate Asco
mycetes, 339-358 (1984), J. Am. C
loculospores in the classification table of Ramer (Loculo
ascomycetes) Pleospora (Pleo)
sporales) Pleospora
racea)).

【0013】 属レベルの同定 本菌株(MCI2799)は1)偽嚢殻は単生し、子座
を形成しない、2)偽嚢殻は植物体組織中に埋没して生
じる、3)偽嚢殻は剛毛や綿毛状菌糸におおわれること
はない、4)子嚢胞子はだ円形〜スリッパ状で糸状の胞
子ではない、5)子嚢胞子は3隔壁以上の横隔壁のみを
有し、縦隔壁を持たない性状を有する。これらの特徴に
基づいて、R.W.G.Dennis,British
Ascomycetes,382〜385 (196
8),J.Cramer,及びA.Sivanesa
n,The Bitunicate Ascomyce
tes,356〜358 (1984)、J.Crame
rのPleosporaceaeの属の検索を行なった
ところ、本菌株はレプトスフェリア属(Leptosp
haeria)に帰属することが判明した。
Identification of genus level This strain (MCI2799) has 1) pseudocapsules that do not form ascidians, 2) pseudocapsules are buried in plant tissues, and 3) pseudocapsules Are not covered by bristles or fluffy hyphae. 4) Ascospores are oval to slipper-shaped, not filamentous spores. 5) Ascospores have only 3 or more transverse septa and longitudinal septa. It has the property of not having. Based on these features, R. W. G. FIG. Dennis, British
Ascomycetes, 382-385 (196)
8). Cramer, and A.A. Sivanesa
n, The Bitunicate Ascomyce
tes, 356-358 (1984), J. Am. Crame
A search of the genus of Pleosporaceae of r revealed that this strain was of the genus Leptosperia.
haeria).

【0014】 種レベルの同定 L.Holm,Taxonomical notes
on Ascomycetes II.,Svensk,
Bot.Tidskr.46:18〜46(1952)
のレプトスフェリア属(Leptosphaeria)
のモノグラフによれば、単子葉植物に着生する菌種とし
て23種、双子葉植物に着生する菌種として37種を記
載している。これらの菌種は着生する宿主の違い、子嚢
の形態、子嚢胞子の諸性質、即ち胞子の形、大きさ、隔
壁数、膨潤細胞の有無や位置、隔壁挿入部のくびれの有
無、色調、付属体の有無等によって区別されている。
L.Holm(1952)の検索表に従って、本菌株
(MCI2799)の種の検索を行なったところ、L.
clivensisが類似種として挙げられた。本菌株
とL.clivensisは、1)偽嚢殻が柔軟で、顕
著な頚部を持つ、2)子嚢は細長い柄(pedice
l)を持ったこん棒形であること、3)子嚢胞子は濃い
暗褐色を呈し、3−隔壁を有する点において類似してい
る。しかし、子嚢及び子嚢胞子の大きさ等について、
L.clivensisと異っていた。L.clive
nsisの子嚢は68〜80μm×13〜16μm、子
嚢胞子は18〜24μm×6〜8μmである、本菌株の
子嚢は120〜132μm×20〜24.5μm、子嚢
胞子は25.9〜34.1μm×8.4〜10μmの大
きさである。さらにL.clivensisは北欧の亜
寒帯圏に分布するのに対し、本菌は琉球列島の亜熱帯域
に分布する種である。従って、本菌はL.cliven
sisに類似した新種と考えられるが、種のレベルの同
定は将来の分類学的検討を待つことにして、ここでは、
レプトスフェリア・エスピー(Leptosphaer
ia sp.)MCI2799と同定する。
Species Level Identification L. Holm, Taxonical notes
on Ascomycetes II. , Svensk,
Bot. Tidskr. 46 : 18-46 (1952)
Genus Leptosphaeria
According to the monograph of No. 23, 23 kinds of fungal species that adhere to monocotyledonous plants and 37 kinds of fungal species that adhere to dicotyledonous plants are described. These bacterial species differ in the host to which they settle, the morphology of the ascos, the properties of the ascospore, that is, the shape and size of the spores, the number of septa, the presence or location of swollen cells, the presence or absence of constriction at the septum insertion part, They are distinguished by the color tone and the presence or absence of attachments.
L. When the species of this strain (MCI2799) was searched according to the search table of Holm (1952), L.
clivensis was mentioned as a similar species. This strain and L. Clivensis has 1) a flexible pseudocapsule and a prominent cervix, 2) an ascidian with a long pedicle.
Being a club with 1), 3) ascospores have a dark dark brown color and are similar in that they have 3 septa. However, regarding the size of ascos and ascospores,
L. It was different from Clivensis. L. clive
The ascos of Nsis is 68 to 80 μm × 13 to 16 μm, the ascospore is of 18 to 24 μm × 6 to 8 μm, the ascos of this strain is 120 to 132 μm × 20 to 24.5 μm, and the ascospore is 25.9. The size is ˜34.1 μm × 8.4 to 10 μm. Furthermore, L. Clivensis is distributed in the subarctic region of Northern Europe, whereas this fungus is a species distributed in the subtropical region of the Ryukyu Islands. Therefore, this bacterium is L. cliven
Although it is considered to be a new species similar to sis, the identification of the level of the species is awaiting future taxonomic study.
Leptospheria sp.
ia sp. ) Identified as MCI2799.

【0015】本発明化合物は、レプトスフェリア属に属
する本発明化合物生産菌を通常の微生物が利用し得る栄
養物を含む培地で培養し、その培養物中から得ることが
できる。かかる培地としては、炭素源としてグルコー
ス、水あめ、デキストリン、シュークロース、デンプ
ン、糖蜜、動・植物油等が使用でき、また窒素源として
は大豆粉、コーンスチープリカー、魚粕、酵母エキス、
肉エキス、ペプトン、その他無機窒素源たとえばアンモ
ニウム塩等が用いられる。また一般に菌の発育または抗
生物質の生産を促進する重金属イオンやその他の微量促
進物質等を添加してもよい。
The compound of the present invention can be obtained from the culture by culturing the compound-producing bacterium of the present invention belonging to the genus Leptosperia in a medium containing nutrients that can be utilized by ordinary microorganisms. As such a medium, glucose as a carbon source, starch syrup, dextrin, sucrose, starch, molasses, animal and vegetable oils can be used, and as a nitrogen source, soybean flour, corn steep liquor, fish meal, yeast extract,
Meat extract, peptone, and other inorganic nitrogen sources such as ammonium salts are used. In addition, heavy metal ions or other trace accelerating substances that generally promote the growth of bacteria or the production of antibiotics may be added.

【0016】上記のような培地により、pH5.0〜
8.0、15〜30℃、好ましくはpH6.0〜7.
0、20〜27℃で数日、好気的に培養される。本発明
のAM−1物質の生産は培地や培養条件により異なる
が、振とう培養、タンク培養とも通常2〜5日の間でそ
の蓄積が最高に達する。培養物中のAM−1物質の蓄積
が最高になったときに培養を停止し、培養物から目的物
質を単離精製する。
Depending on the medium as described above, a pH of 5.0-
8.0, 15 to 30 ° C., preferably pH 6.0 to 7.
It is aerobically cultured at 0 to 20 to 27 ° C for several days. The production of the AM-1 substance of the present invention varies depending on the medium and culture conditions, but the maximum accumulation is usually reached within 2 to 5 days in both shaking culture and tank culture. When the accumulation of the AM-1 substance in the culture reaches the maximum, the culture is stopped, and the target substance is isolated and purified from the culture.

【0017】本発明のAM−1物質を培養物から単離、
精製するには、上記微生物の培養物中からその性状を利
用した通常の分離手段、たとえば溶媒抽出、吸着または
分配カラムクロマトグラフィー、高速液体クロマトグラ
フィー等を適宜組合わせて行う。かくして得られる本発
明化合物は、後述の試験例に示すように、野生株には抗
菌活性を示さないが、キチン合成酵素1欠損株には抗菌
活性を有していた。
Isolation of the AM-1 substance of the invention from the culture,
Purification is carried out by appropriately combining ordinary separation means utilizing the properties of the culture of the above-mentioned microorganism, for example, solvent extraction, adsorption or partition column chromatography, high performance liquid chromatography and the like. The compound of the present invention thus obtained does not show antibacterial activity in the wild strain, but has antibacterial activity in the chitin synthase 1-deficient strain, as shown in the test examples described later.

【0018】[0018]

【発明の効果】以下の試験例から明らかなように、本発
明のAM−1物質は真菌の細胞壁合成酵素であるキチン
合成酵素1を欠損する変異株に対して抗真菌活性を示
し、野生株には抗真菌活性を示さない新しいタイプの抗
真菌剤として有用である。また今後の有効真菌剤のリー
ド化合物としても期待できる。
As is apparent from the following test examples, the AM-1 substance of the present invention exhibits antifungal activity against mutant strains lacking fungal cell wall synthesizing enzyme chitin synthase 1, Is useful as a new type of antifungal agent that does not exhibit antifungal activity. It can also be expected as a lead compound for future effective fungal agents.

【0019】[0019]

【実施例】以下に本発明を実施例により詳細に説明する
が、本発明はその要旨を越えない限り以下の実施例に限
定されるものではない。 実施例1 1)培養 フラクトース3%、大豆粉0.5%、リン酸1カリウム
0.1%、硫酸マグネシウム(7水和物)0.05%、
塩化カルシウム0.01%を含有する培地(pH6.
0)を7.0mlずつ500mlのフラスコに分注し、
121℃において20分間高圧滅菌した。これに本菌株
(MCI2799)を1白金耳ずつ接種して、27℃3
日間振とう培養した。得られた培養物を、麦芽エキス
3.5%、コーンスターチ3.0%、コーンスティープ
リカー1.5%、ファーマメディア1.5%、サングレ
イン0.5%、炭酸カルシウム0.3%を含有する培地
(pH6.0)20リットルを仕込んだ30リットルジ
ャーに200ml接種し、27℃で4日間通気撹拌培養
を行った。
EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited to the following examples as long as the gist thereof is not exceeded. Example 1 1) Cultured fructose 3%, soybean flour 0.5%, potassium phosphate 1% 0.1%, magnesium sulfate (heptahydrate) 0.05%,
Medium containing 0.01% calcium chloride (pH 6.
0) was dispensed 7.0 ml each into a 500 ml flask,
It was autoclaved at 121 ° C. for 20 minutes. This strain (MCI2799) was inoculated in 1 platinum loop at 27 ° C for 3 hours.
The cells were cultured with shaking for days. The resulting culture contains malt extract 3.5%, corn starch 3.0%, corn steep liquor 1.5%, pharmacomedia 1.5%, sun grains 0.5%, calcium carbonate 0.3% 200 ml was inoculated into a 30-liter jar charged with 20 liter of the culture medium (pH 6.0) and cultured at 27 ° C. for 4 days with aeration and stirring.

【0020】2)精製 得られた培養物を遠心分離して、上清と菌体に分け、上
清はダイヤイオンHP−20(三菱化学製)に吸着さ
せ、水洗、50%メタノールで洗浄後、70%メタノー
ルで溶出させた。70%メタノール溶出画分を濃縮乾固
後、クロロホルム/メタノール=9/1で平衡化させた
シリカゲルカラムに付し、活性画分をクロロホルム/メ
タノール=85/15で溶出させた。 上記培養物遠心分離により得られた菌体はn−ブタノー
ルで抽出し、ブタノール層を濃縮、乾固した後、クロロ
ホルム/メタノール=9/1で平衡化したシリカゲルカ
ラムに付し、活性画分をクロロホルム/メタノール=8
5/15で溶出させ、上清より得た同画分を合わせた。
2) Purification The obtained culture was centrifuged to separate into supernatant and cells, and the supernatant was adsorbed on Diaion HP-20 (manufactured by Mitsubishi Chemical), washed with water and washed with 50% methanol. , 70% methanol was eluted. The 70% methanol elution fraction was concentrated to dryness, and then applied to a silica gel column equilibrated with chloroform / methanol = 9/1, and the active fraction was eluted with chloroform / methanol = 85/15. The cells obtained by the above-mentioned culture centrifugation were extracted with n-butanol, the butanol layer was concentrated and dried, and then applied to a silica gel column equilibrated with chloroform / methanol = 9/1 to obtain an active fraction. Chloroform / methanol = 8
Elution was performed at 5/15, and the same fractions obtained from the supernatant were combined.

【0021】上記で合わせた画分を、濃縮乾固し、再度
クロロホルム/メタノール=9/1で平衡化したシリカ
ゲルカラムに付し、活性画分をクロロホルム/メタノー
ル=85/15で溶出させた。活性画分を濃縮、乾固
し、分取用薄層クロマトグラフィー(Merk Ar
t.13895)に付し、ベンゼン/アセトン=7/3
で展開した。活性画分をかきとり、メタノールで抽出
後、濃縮乾固し、分取用薄層クロマトグラフィー(Me
rkArt.13895)に付し、クロロホルム/メタ
ノール=7/3で展開した。活性画分をかきとり、メタ
ノールで抽出後、濃縮乾固し、薄層クロマトグラフィー
(Merk Art.5744)に付し、ベンゼン/メ
タノール/クロロホルム=8/2/1で展開した。活性
画分をかきとり、メタノールで抽出後、濃縮乾固し、薄
層クロマトグラフィー(Merk Art.5744)
に付し、ベンゼン/メタノール/クロロホルム/エチル
エーテル=8/2/1/1で展開した。活性画分をかき
とり、メタノールで抽出後、乾固し、AM−1物質を得
た。得られたAM−1物質の理化学的性質は前述のとお
りであった。
The fractions combined above were concentrated to dryness and again applied to a silica gel column equilibrated with chloroform / methanol = 9/1, and the active fraction was eluted with chloroform / methanol = 85/15. The active fraction was concentrated, dried, and subjected to preparative thin layer chromatography (Merck Ar).
t. 13895), benzene / acetone = 7/3
Unfolded. The active fraction is scraped off, extracted with methanol, concentrated to dryness, and subjected to preparative thin layer chromatography (Me.
rkArt. 13895) and developed with chloroform / methanol = 7/3. The active fraction was scraped off, extracted with methanol, concentrated to dryness, subjected to thin layer chromatography (Merk Art. 5744), and developed with benzene / methanol / chloroform = 8/2/1. The active fraction is scraped off, extracted with methanol, concentrated to dryness, and thin layer chromatography (Merk Art. 5744).
And developed with benzene / methanol / chloroform / ethyl ether = 8/2/1/1. The active fraction was scraped off, extracted with methanol and then dried to obtain AM-1 substance. The physicochemical properties of the obtained AM-1 substance were as described above.

【0022】試験例1 0.42mgのAM−1物質を1mlのメタノールに溶
解し、その60μlを直径8mmのペーパーディスクに
しみこませ、風乾した。野生型サッカロマイセス・セレ
ビシアエ及びキチン合成酵素1を欠損する変異サッカロ
マイセス・セレビシアエ(北海道大学農学部応用菌学講
座から入手可能)を、各々菌数を106CFU(Col
ony Forming Unit)/mlに調整した
菌液を、酵母エキス0.1%、ポリペプトン0.2%、
グルコース0.2%、寒天0.15%を含む寒天培地に
混合し、抗菌活性測定培地を作製した。この培地表面
に、上記AM−1を含むペーパーディスクをのせ、27
℃、18時間培養後、できた阻止円を測定したところ、
変異株では16mmの生育阻止円を形成したが、野生株
では生育阻止円は認められなかった。 以上の結果から、本発明のAM−1物質は、真菌の細胞
壁合成酵素であるキチン合成酵素1を欠損する変異株に
対して抗真菌活性を示し、野生株には抗真菌活性を示さ
ないことが明らかである。
Test Example 1 0.42 mg of the AM-1 substance was dissolved in 1 ml of methanol, and 60 μl thereof was soaked in a paper disk having a diameter of 8 mm and air dried. Wild-type Saccharomyces cerevisiae and mutant Saccharomyces cerevisiae deficient in chitin synthase 1 (available from Hokkaido University Faculty of Agriculture, Department of Applied Bacteriology) were each used at 10 6 CFU (Col).
Bacterial fluid adjusted to ony Forming Unit) / ml, yeast extract 0.1%, polypeptone 0.2%,
An antibacterial activity measurement medium was prepared by mixing with an agar medium containing glucose 0.2% and agar 0.15%. Place a paper disc containing AM-1 on the surface of this medium, and
After culturing at ℃ for 18 hours, the resulting inhibition circle was measured.
A 16 mm growth inhibition circle was formed in the mutant strain, but no growth inhibition circle was observed in the wild strain. From the above results, the AM-1 substance of the present invention exhibits antifungal activity against a mutant strain lacking chitin synthase 1 which is a fungal cell wall synthase, and does not exhibit antifungal activity in a wild strain. Is clear.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:645) (C12P 1/04 C12R 1:645) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location C12R 1: 645) (C12P 1/04 C12R 1: 645)

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】下記の理化学的性質を有するAM−1物
質。 (1)分子量:m/z=337(FAB−MS) (2)分子式:C2243ON (3)紫外部吸収スペクトル:メタノール中、248n
mおよび286(sh)nmに吸収極大を有する (4)薄層クロマトグラフィー:以下の展開溶媒条件で
以下のRf値を示す 【表1】 (5)呈色反応:ヨウ素反応に陽性
1. An AM-1 substance having the following physicochemical properties. (1) Molecular weight: m / z = 337 (FAB-MS) (2) Molecular formula: C 22 H 43 ON (3) Ultraviolet absorption spectrum: in methanol, 248 n
Absorption maxima at m and 286 (sh) nm (4) Thin layer chromatography: The following Rf values are shown under the following developing solvent conditions. (5) Color reaction: Positive in iodine reaction
【請求項2】レプトスフェリア属に属し、請求項1記載
のAM−1物質を生産する能力を有する微生物を培養
し、その培養物からAM−1物質を採取することを特徴
とする請求項1記載のAM−1物質の製造法。
2. A microorganism belonging to the genus Leptosperia, which has the ability to produce the AM-1 substance according to claim 1, is cultured, and the AM-1 substance is collected from the culture. A method for producing the AM-1 substance described.
【請求項3】レプトスフェリア・エスピーMCI279
9(FERM P−15016)。
3. Leptosperia sp. MCI279
9 (FERM P-15016).
JP7168616A 1995-07-04 1995-07-04 Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production Pending JPH0920791A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7168616A JPH0920791A (en) 1995-07-04 1995-07-04 Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7168616A JPH0920791A (en) 1995-07-04 1995-07-04 Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production

Publications (1)

Publication Number Publication Date
JPH0920791A true JPH0920791A (en) 1997-01-21

Family

ID=15871367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7168616A Pending JPH0920791A (en) 1995-07-04 1995-07-04 Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production

Country Status (1)

Country Link
JP (1) JPH0920791A (en)

Similar Documents

Publication Publication Date Title
JPH0815434B2 (en) Novel antibiotic vermisporin and method for producing the same
Tomoda et al. Roselipins, inhibitors of diacylglycerol acyltransferase, produced by Gliocladium roseum KF-1040
US5407826A (en) Isolated cultures of microorganisms of Clonostachys Cylindrospora, Gliocladium and Nectria Gliocladioides
JPH0920791A (en) Chitin-synthesizing enzyme-inhibiting substance am-1 substance and its production
JP2768829B2 (en) Antibiotics
JPH0740950B2 (en) Microbial production of nicotianamine
JPH05170769A (en) New compound q-11270 or its production
JPH06234784A (en) New antibiotic sf 2768 substance and its production
JPH0265775A (en) Novel microorganism and production of gibberellins
JPS5920350B2 (en) New antibiotic acreacin Aα and its production method
JPH07107989A (en) New antibiotic mk8062 substance and its production
JPH0474163A (en) New physiologically active substance mbp049-13 and production thereof
JPH05239023A (en) Physiologically active substance mbp039-06 and its production
JP2827417B2 (en) Demethyl allosamidine and its production
JPH05155876A (en) Novel antibiotics: mer-af1032a and mer-af1032b
JPH05202081A (en) New physiologically active substance and its production
EP0525846A1 (en) Sporomiella intermedia and processes therefrom
JPH05247077A (en) New physiologically active substance d101 and its production
JPH0380160B2 (en)
JPH0662632B2 (en) Novel antibiotic A1-R2397 substance and its production method
JPH07133287A (en) New compound mk7924 and its production
JPH0627102B2 (en) New substance UCN-1028A
JPH05207894A (en) Production of macrolide antibiotic
JPH03201991A (en) New antibiotic pf1042 substance and production thereof
JPS6143182A (en) Novel antibiotic ss19508d and preparation thereof